Oka J I, Goto N, Kameyama T
Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Meijo University, Nagoya, Japan.
Neuroreport. 1999 Jun 3;10(8):1643-6. doi: 10.1097/00001756-199906030-00004.
In order to assess effects of glucagon-like peptide-1 (GLP-1) in the brain excluding the hypothalamus, the effects of GLP-1 (7-36) amide, a naturally produced active fragment, on the electroencephalogram and hippocampal single unit activities of anesthetized male Wistar rats were examined. I.c.v. injection of GLP-1 (7-36) amide decreased the hippocampal theta wave duration. Juxtacellular administration of GLP-1 (7-36) amide first increased and then decreased single unit activities recorded in the hippocampal CA1, which effects were antagonized by exendin (9-39) amide, a GLP-1 receptor antagonist, or 6-cyano-7-nitroquinoxaline-2,3-dione, a non-NMDA type glutamate receptor antagonist. These results indicate that GLP-1 receptors exist in the hippocampus and are involved in modulating hippocampal activity through an increase in the release of excitatory amino acid transmitters.
为了评估胰高血糖素样肽-1(GLP-1)在不包括下丘脑的大脑中的作用,研究了天然产生的活性片段GLP-1(7-36)酰胺对麻醉的雄性Wistar大鼠脑电图和海马单单位活动的影响。脑室内注射GLP-1(7-36)酰胺可缩短海马θ波持续时间。对海马CA1区记录的单单位活动进行细胞旁给药GLP-1(7-36)酰胺,其活性先增加后降低,这些作用可被GLP-1受体拮抗剂艾塞那肽(9-39)酰胺或非NMDA型谷氨酸受体拮抗剂6-氰基-7-硝基喹喔啉-2,3-二酮所拮抗。这些结果表明,GLP-1受体存在于海马中,并通过增加兴奋性氨基酸递质的释放参与调节海马活动。